FDA less trusted than pharma, says poll

Share this article:
A poll suggests that, amid drug safety worries, the FDA is less trusted than the drug industry.
A recent Wall Street Journal Online/Harris Interactive Health Care Poll found that six in 10 adults gave the agency a negative rating on the function they rated its most important: ensuring the safety and efficacy of prescription drugs.

Eighty percent of respondents said they were very or somewhat concerned about the agency's ability to “make independent decisions that will ensure that patients have access to safe and effective medicines.” Asked how good a job the FDA is doing on that front, 58% said “fair” or “poor,” while just 36% said “good” or “excellent,” a reversal from ratings two years ago.

By comparison, only 36% of those surveyed in a recent Harris Interactive industry reputation poll said pharmaceutical firms were doing a bad job of serving consumers, with 61% saying they were doing a good job.

Share this article:
close

Next Article in News

Email Newsletters

More in News

Lilly's cancer drug ramu granted gastric indication

Lilly's cancer drug ramu granted gastric indication

Ramucirumab received FDA approval today in advanced gastric cancer, a nod that could translate into $600 million in peak sales.

GSK, Novartis, Lilly play musical chairs

GSK, Novartis, Lilly play musical chairs

The three drugmakers rearranged part of the pharma universe Tuesday with a string of pipeline-altering deals.

Valeant bids $47B for Allergan

Valeant bids $47B for Allergan

The deal would bring Allergan's Botox and Juvederm under the same roof as Restylane.